Lexicon Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.87-3.848.341.80
Price/Sales ratio
1.720.860.480.31
Earnings per Share (EPS)
$-0.60$-0.29$0.13$0.63

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.84-294.48-10.15-8.04-5.823.38-5.40-6.50-3.06-1.91-3.93-5.82
Price/Sales ratio
21.2710.6017.2311.4911.101.3615.791.92K2.27K281.002.88K11.10
Price/Book Value ratio
1.714.829.1219.93-0.47-0.322.42-0.38-0.193.633.42-0.47
Price/Cash Flow ratio
-6.437.46-8.17-5.60-4.723.87-2.65-6.59-3.56-2.08-4.51-4.72
Price/Free Cash Flow ratio
-6.427.49-8.16-5.59-4.723.87-2.64-6.50-3.51-2.08-4.44-4.72
Price/Earnings Growth ratio
0.623.05-0.000.840.79-0.010.032.04-1.87-0.061.130.79
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-290.64%26.78%-96.75%97.89%96.05%98.99%91.96%-18371.81%-207.19%92.94%N/A98.99%
Operating Profit Margin
-439.16%1.12%-164.57%-151.30%-163.39%43.91%-745.09%-29224.83%-72489.20%-14264.95%-72489.20%43.91%
Pretax Profit Margin
-439.15%-3.60%-169.70%-156.87%-190.71%38.53%-244.10%-29448.99%-73341.00%-14710.88%-73341.00%38.53%
Net Profit Margin
-438.84%-3.60%-169.70%-142.85%-190.71%40.40%-292.49%-29620.13%-74192.80%-14710.88%-73341.00%40.40%
Effective Tax Rate
0.06%-128.04%-3.18%8.93%-2.91%-4.84%-19.82%-0.58%-1.16%N/AN/A-2.91%
Return on Assets
-21.27%-0.71%-29.73%-29.56%-42.42%31.15%-34.43%-64.47%-53.07%-77.19%-52.46%31.15%
Return On Equity
-35.31%-1.63%-89.85%-247.68%8.19%-9.70%-44.88%5.93%6.48%-190.22%-96.02%-9.70%
Return on Capital Employed
-23.53%0.27%-44.10%-43.75%-41.74%40.14%-113.88%-75.87%-58.88%-86.79%-58.88%40.14%
Liquidity Ratios
Current Ratio
8.204.322.172.594.715.163.36N/AN/AN/A6.074.71
Quick Ratio
8.094.322.172.574.585.103.364.016.075.585.974.58
Cash ratio
7.544.232.102.504.350.552.692.892.000.712.000.55
Days of Sales Outstanding
16.522.5532.8119.4934.2064.066.0017.1473.52306.1873.5234.20
Days of Inventory outstanding
19.470.00N/A374.41685.74479.320.00N/AN/A1.63KN/A479.32
Operating Cycle
36.002.5532.81393.91719.95543.396.0017.1473.521.94KN/A543.39
Days of Payables Outstanding
53.4075.63117.707.45K1.76K1.37K1.03K60.688.88K61.78KN/A1.37K
Cash Conversion Cycle
-17.40-73.07-84.88-7.05K-1.04K-832.33-1.02K-43.53-8.81K-59.84KN/A-1.04K
Debt Ratios
Debt Ratio
0.220.150.210.560.860.580.05N/A0.250.430.390.58
Debt Equity Ratio
0.370.360.644.71-0.16-0.180.07N/A-0.031.060.65-0.16
Long-term Debt to Capitalization
0.230.260.350.81-0.19-0.21N/AN/A-0.030.510.31-0.19
Total Debt to Capitalization
0.270.260.390.82-0.19-0.220.06N/A-0.030.510.32-0.19
Interest Coverage Ratio
-38.091.63-20.99-19.26-4.978.22-12.29N/AN/AN/A-36.248.22
Cash Flow to Debt Ratio
-0.701.79-1.73-0.75-0.600.46-12.27N/A-1.82-1.62-1.600.46
Company Equity Multiplier
1.652.293.028.37-0.19-0.311.30-0.09-0.122.461.65-0.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-3.301.42-2.10-2.05-2.350.35-5.95-292.00-639.21-134.46-639.210.35
Free Cash Flow / Operating Cash Flow Ratio
1.000.991.001.001.000.991.001.011.011.001.011.00
Cash Flow Coverage Ratio
-0.701.79-1.73-0.75-0.600.46-12.27N/A-1.82-1.62-1.600.46
Short Term Coverage Ratio
-3.7493.51-10.78-13.15-133.2710.33-12.27N/AN/AN/A-68.82-133.27
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A